Cancer Research, Statistics, and Treatment (Jan 2023)

Erdafitinib can combat FGFR-mediated abnormal signaling in cancer

  • Sisir Nandi

DOI
https://doi.org/10.4103/crst.crst_259_23
Journal volume & issue
Vol. 6, no. 3
pp. 490 – 491

Abstract

Read online

No abstracts available.